Header Logo

Connection

Annabelle Volgman to Male

Back to Details
This is a "connection" page, showing publications Annabelle Volgman has written about Male.
Annabelle Volgman
Connection Strength
1.252
Male
  1. Sex differences in permanent pacemaker implantation after transcatheter aortic valve replacement: a systematic review and meta-analysis. Expert Rev Cardiovasc Ther. 2023 Jul-Dec; 21(9):631-641.
    View in: PubMed
    Score: 0.072
  2. Vascular Cognitive Impairment: A Little Bit of Good News for Women or Bad News for Men? J Alzheimers Dis. 2023; 95(2):407-409.
    View in: PubMed
    Score: 0.069
  3. Managing Ischemic Heart Disease in Women: Role of a Women's Heart Center. Curr Atheroscler Rep. 2021 08 04; 23(10):56.
    View in: PubMed
    Score: 0.062
  4. Impact of Atrial Fibrillation on Hospitalization Outcomes of Heart Failure in Patients = 60 Years with Implantable Cardioverter Defibrillator. Am J Cardiol. 2021 08 01; 152:94-98.
    View in: PubMed
    Score: 0.062
  5. Sex Differences in COVID-19 Hospitalization and Mortality. J Womens Health (Larchmt). 2021 05; 30(5):646-653.
    View in: PubMed
    Score: 0.061
  6. Women and atrial fibrillation. J Cardiovasc Electrophysiol. 2021 10; 32(10):2793-2807.
    View in: PubMed
    Score: 0.060
  7. Economic Impact of Atrial Fibrillation on Hospitalization Outcomes of Acute Heart Failure in the United States. Am J Cardiol. 2021 01 01; 138:124-127.
    View in: PubMed
    Score: 0.059
  8. Sex-Based Considerations in the Evaluation of Chest Pain and Management of Obstructive Coronary Artery Disease. Curr Atheroscler Rep. 2020 06 23; 22(8):39.
    View in: PubMed
    Score: 0.058
  9. Sex Differences in Cardiovascular Disease and Cognitive Impairment: Another Health Disparity for Women? J Am Heart Assoc. 2019 10; 8(19):e013154.
    View in: PubMed
    Score: 0.055
  10. Sex Differences in Takotsubo Syndrome: A Narrative Review. J Womens Health (Larchmt). 2020 08; 29(8):1122-1130.
    View in: PubMed
    Score: 0.055
  11. Feasibility of a Lifestyle Physical Activity Intervention to Prevent Memory Loss in Older Women With Cardiovascular Disease: A Mixed-Methods Approach. Can J Nurs Res. 2020 Dec; 52(4):278-289.
    View in: PubMed
    Score: 0.054
  12. Atrial Fibrillation and Heart Failure in Women. Heart Fail Clin. 2019 Jan; 15(1):55-64.
    View in: PubMed
    Score: 0.051
  13. Should Sex Matter When it Comes to High-Intensity Statins? J Am Coll Cardiol. 2018 04 24; 71(16):1738-1740.
    View in: PubMed
    Score: 0.050
  14. Single-lead portable ECG devices: Perceptions and clinical accuracy compared to conventional cardiac monitoring. J Electrocardiol. 2015 Jul-Aug; 48(4):710-6.
    View in: PubMed
    Score: 0.040
  15. Study of warfarin patients investigating attitudes toward therapy change (SWITCH Survey). Am J Ther. 2012 Nov; 19(6):432-5.
    View in: PubMed
    Score: 0.034
  16. Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statins. Gend Med. 2008 Mar; 5(1):53-61.
    View in: PubMed
    Score: 0.025
  17. Cardiovascular disease in Filipino American men and women: A 2023 update. Am Heart J. 2023 12; 266:1-13.
    View in: PubMed
    Score: 0.018
  18. Sex Differences in Periprocedural and Long-Term Outcomes Following Transcatheter Left Atrial Appendage Occlusion: A Systematic Review and Meta-Analysis. Cardiovasc Revasc Med. 2023 03; 48:23-31.
    View in: PubMed
    Score: 0.017
  19. Ischemic Heart Disease in Young Women: JACC Review Topic of the Week. J Am Coll Cardiol. 2022 09 06; 80(10):1014-1022.
    View in: PubMed
    Score: 0.017
  20. Women Are Less Likely to Survive AMI Presenting With Out-of-Hospital Cardiac Arrest: A Nationwide Study. Mayo Clin Proc. 2022 09; 97(9):1608-1618.
    View in: PubMed
    Score: 0.017
  21. Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19. J Am Heart Assoc. 2022 09 20; 11(18):e025198.
    View in: PubMed
    Score: 0.017
  22. Addressing disparities of care in non-ST-segment elevation myocardial infarction patients without standard modifiable risk factors: insights from a nationwide cohort study. Eur J Prev Cardiol. 2022 05 25; 29(7):1084-1092.
    View in: PubMed
    Score: 0.016
  23. The prognostic value of cardiac troponin for 60 day mortality and major adverse events in COVID-19 patients. Cardiovasc Pathol. 2021 Nov-Dec; 55:107374.
    View in: PubMed
    Score: 0.016
  24. Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week. J Am Coll Cardiol. 2021 06 15; 77(23):2960-2972.
    View in: PubMed
    Score: 0.015
  25. Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association. Circ Genom Precis Med. 2021 06; 14(3):e000082.
    View in: PubMed
    Score: 0.015
  26. Sex Differences Remain Under-Reported in Cardiovascular Publications. J Womens Health (Larchmt). 2021 09; 30(9):1253-1258.
    View in: PubMed
    Score: 0.015
  27. A study protocol for MindMoves: A lifestyle physical activity and cognitive training intervention to prevent cognitive impairment in older women with cardiovascular disease. Contemp Clin Trials. 2021 02; 101:106254.
    View in: PubMed
    Score: 0.015
  28. Impact of Gender Differences on Outcomes of Peripheral Artery Disease Intervention (from a Nationwide Sample). Am J Cardiol. 2021 02 15; 141:127-132.
    View in: PubMed
    Score: 0.015
  29. Sex Differences in the Age of Diagnosis for Cardiovascular Disease and Its Risk Factors Among US Adults: Trends From 2008 to 2017, the Medical Expenditure Panel Survey. J Am Heart Assoc. 2020 12 15; 9(24):e018764.
    View in: PubMed
    Score: 0.015
  30. Cochrane corner: transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk. Heart. 2020 07; 106(14):1043-1045.
    View in: PubMed
    Score: 0.014
  31. Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 05 26; 75(20):2602-2618.
    View in: PubMed
    Score: 0.014
  32. Socioeconomic Status and Differences in the Management and Outcomes of 6.6 Million US Patients With Acute Myocardial Infarction. Am J Cardiol. 2020 08 15; 129:10-18.
    View in: PubMed
    Score: 0.014
  33. Sex differences in rates and causes of 30-day readmissions after cardiac electronic device implantations: insights from the Nationwide Readmissions Database. Int J Cardiol. 2020 03 01; 302:67-74.
    View in: PubMed
    Score: 0.014
  34. Readmission and processes of care across weekend and weekday hospitalisation for acute myocardial infarction, heart failure or stroke: an observational study of the National Readmission Database. BMJ Open. 2019 08 22; 9(8):e029667.
    View in: PubMed
    Score: 0.014
  35. Trends of Sex Differences in Outcomes of Cardiac Electronic Device Implantations in the United States. Can J Cardiol. 2020 01; 36(1):69-78.
    View in: PubMed
    Score: 0.014
  36. Prevalence, Outcomes, and Costs According to Patient Frailty Status for 2.9 Million Cardiac Electronic Device Implantations in the United States. Can J Cardiol. 2019 11; 35(11):1465-1474.
    View in: PubMed
    Score: 0.014
  37. Discharge against medical advice after hospitalisation for acute myocardial infarction. Heart. 2019 02; 105(4):315-321.
    View in: PubMed
    Score: 0.013
  38. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol. 1998 May; 31(6):1414-9.
    View in: PubMed
    Score: 0.012
  39. Sex Differences in Ischemic Heart Disease: Advances, Obstacles, and Next Steps. Circ Cardiovasc Qual Outcomes. 2018 02; 11(2):e004437.
    View in: PubMed
    Score: 0.012
  40. Effect of left atrial size on recurrence of atrial fibrillation after electrical cardioversion: atrial dimension versus volume. Am J Card Imaging. 1996 Oct; 10(4):261-5.
    View in: PubMed
    Score: 0.011
  41. Reproducibility of programmed electrical stimulation responses in patients with ventricular tachycardia or fibrillation associated with coronary artery disease. Am J Cardiol. 1992 Sep 15; 70(7):758-63.
    View in: PubMed
    Score: 0.008
  42. Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials. Eur Heart J. 2006 Aug; 27(16):1947-53.
    View in: PubMed
    Score: 0.005
  43. Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2006 Feb; 151(2):390-6.
    View in: PubMed
    Score: 0.005
  44. Alternative endpoints for mortality in studies of patients with atrial fibrillation: the AFFIRM study experience. Heart Rhythm. 2004 Nov; 1(5):531-7.
    View in: PubMed
    Score: 0.005
  45. Cardiac rhythm disturbances among children with idiopathic congenital central hypoventilation syndrome. Pediatr Pulmonol. 2000 May; 29(5):351-8.
    View in: PubMed
    Score: 0.004
  46. Does atrial fibrillation cause false-positive late potentials? Pacing Clin Electrophysiol. 1993 Dec; 16(12):2222-6.
    View in: PubMed
    Score: 0.002
  47. Beneficial effects of dextro-amphetamine in the treatment of vasodepressor syncope. Pacing Clin Electrophysiol. 1993 Jun; 16(6):1235-9.
    View in: PubMed
    Score: 0.002
  48. In anterior myocardial infarction, frequency domain is better than time domain analysis of the signal-averaged ECG for identifying patients at risk for sustained ventricular tachycardia. Pacing Clin Electrophysiol. 1992 Nov; 15(11 Pt 1):1681-7.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.